presented a data supporting the association between serum OPG levels and the risk of cardiovascular mortality in patients with CKD stages 3 to 5 (including those undergoing dialysis), while only a limited numbers of the patients were included (n = 145)24. The gene discussed is TNFRSF11B; the disease is chronic kidney disease.